CN106977413B - A kind of preparation method of DL- L-aminobutanedioic acid DL- ornithine - Google Patents

A kind of preparation method of DL- L-aminobutanedioic acid DL- ornithine Download PDF

Info

Publication number
CN106977413B
CN106977413B CN201710239961.1A CN201710239961A CN106977413B CN 106977413 B CN106977413 B CN 106977413B CN 201710239961 A CN201710239961 A CN 201710239961A CN 106977413 B CN106977413 B CN 106977413B
Authority
CN
China
Prior art keywords
preparation
acid
ornithine
aminobutanedioic
racemization
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201710239961.1A
Other languages
Chinese (zh)
Other versions
CN106977413A (en
Inventor
夏继祥
张勇
刘兆祥
单永继
张祖杨
李保琴
胡志国
宋强君
刘德光
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Anhui BBCA Pharmaceutical Co Ltd
Original Assignee
Anhui BBCA Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anhui BBCA Pharmaceutical Co Ltd filed Critical Anhui BBCA Pharmaceutical Co Ltd
Priority to CN201710239961.1A priority Critical patent/CN106977413B/en
Publication of CN106977413A publication Critical patent/CN106977413A/en
Application granted granted Critical
Publication of CN106977413B publication Critical patent/CN106977413B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/36—Racemisation of optical isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/38—Separation; Purification; Stabilisation; Use of additives
    • C07C227/40—Separation; Purification
    • C07C227/42—Crystallisation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The present invention relates to a kind of methods for preparing raceme aspartic acid ornithine.The preparation method comprises the following steps: (1) using acetic acid aqueous solution as solvent, racemization occurs under the action of catalyst for L-ASPARTIC ACID L-Orn salt, obtains racemization liquid;(2) be added anti-solvent into racemization liquid, crystallization, filtering, drying to get.Preparation method raw material provided by the invention is easy to get, easy to operate, and easily controllable, preparation process is reliable and stable, is suitble to large-scale production raceme aspartic acid ornithine sample.

Description

A kind of preparation method of DL- L-aminobutanedioic acid DL- ornithine
Technical field
The present invention relates to a kind of preparation methods of DL- L-aminobutanedioic acid DL- ornithine, belong to technology of pharmaceutical engineering field.
Background technique
DL- L-aminobutanedioic acid DL- ornithine is chirality that may be present in L-ASPARTIC ACID L-Orn bulk pharmaceutical chemicals and preparation Impurity.Its structural formula is as follows:
Although used in L-ASPARTIC ACID L-Orn quality standard the method for specific rotation to problem chiral in compound into Go certain control, but the content of the wherein chiral isomer of the proof without standard measure.
In order to accurately detect the content of chiral photo-isomerisation in L-ASPARTIC ACID L-Orn bulk pharmaceutical chemicals and preparation, so that it is guaranteed that L- The quality of L-aminobutanedioic acid L-Orn needs the DL- L-aminobutanedioic acid DL- ornithine of high-purity as the working reference substance of detection.
Summary of the invention
The object of the present invention is to provide a kind of preparation method of DL- L-aminobutanedioic acid DL- ornithine, gained DL- L-aminobutanedioic acids Detection of the DL- ornithine for chiral isomer content in L-ASPARTIC ACID L-Orn bulk pharmaceutical chemicals and preparation.The present invention provides Preparation method raw material be easy to get, easy to operate, easily controllable, gained raceme DL- L-aminobutanedioic acid DL- ornithine purity is high produces Rate is higher, is suitble to large-scale production preparation.
To achieve the goals above, described the present invention provides a kind of preparation method of DL- L-aminobutanedioic acid DL- ornithine Method the following steps are included:
(1) using acetic acid aqueous solution as solvent, racemization occurs under the action of catalyst for L-ASPARTIC ACID L-Orn salt, Obtain racemization liquid;
(2) be added anti-solvent into racemization liquid, crystallization, filtering, drying to get.
The reaction mechanism mechanism of reaction of the racemization is as follows:
In the step (1), the mass concentration of the acetic acid aqueous solution is 40~60%;The addition of the acetic acid aqueous solution Amount is 4~7 times, preferably 5~6 times of L-ASPARTIC ACID L-Orn salt quality.
In the step (1), the catalyst is selected from salicylide or benzaldehyde;The dosage of the catalyst is L- winter ammonia The 5~10% of sour L-Orn salt quality, preferably 8~10%, to guarantee to obtain preferable racemization effect.
In the step (1), the temperature of the racemization is controlled between 60~80 DEG C, preferably between 70~80 DEG C And 3~4h of stirring.
In the step (2), the anti-solvent is selected from one of methanol, ethyl alcohol, isopropanol or a variety of.The anti-solvent Mass ratio with acetic acid aqueous solution is (0.8~1): 1, preferably (0.9~1): 1, further preferably 1:1;Selection is suitable anti- Solvent and dosage can not only guarantee that gained crystalline particle is dimensioned for, and be easy to filter, and can guarantee product yield.
In the step (2), the anti-solvent need to be added in racemization liquid in a manner of dropwise addition, and time for adding should be controlled 1 ~4h, preferably 2~3h, and ensure be added dropwise during temperature control at 45~65 DEG C, preferably 50~60 DEG C;So be conducive to crystalline substance It the growth of body and is slowly precipitated, to obtain that purity is higher and larger-size crystal, is conducive to subsequent filter processing.
In the step (2), after the crystallization, system is cooled to 20~40 DEG C, preferably 30~35 DEG C, with simultaneous Care for production efficiency and product quality.
In the step (2), the drying uses vacuum drying mode, and temperature controls between 40~60 DEG C, and preferably 45 ~50 DEG C, drying time is 4~8h, and preferably 6h, vacuum degree is -0.08~-0.1MPa.
As a preferred embodiment of the present invention, the preparation method of the DL- L-aminobutanedioic acid DL- ornithine includes following step It is rapid:
(1) L-ASPARTIC ACID L-Orn salt is added in acetic acid aqueous solution and is dissolved completely, catalyst is added, heating exists Racemization is carried out between 60~80 DEG C, obtains racemization liquid;
(2) under heat-retaining condition, anti-solvent is added dropwise into racemization liquid, temperature control is at 45~65 DEG C during dropwise addition, simultaneously A large amount of crystal are precipitated, rear 2~4h of insulated and stirred is added dropwise, are cooled to 20~40 DEG C of crystallizations, the solid was filtered, in 40~60 DEG C Carry out vacuum drying to get.
Preparation method raw material provided by the invention is easy to get, easy to operate, easily controllable, gained raceme DL- L-aminobutanedioic acid DL- ornithine purity is high, yield is higher, is suitble to large-scale production preparation.
Specific embodiment
The following examples are used to illustrate the present invention, but are not intended to limit the scope of the present invention..Unless otherwise specified, embodiment Used in the conventional means that are well known to those skilled in the art of technological means, raw materials used is commercial goods.
The preparation of embodiment 1:DL- L-aminobutanedioic acid DL- ornithine
1) L-ASPARTIC ACID L-Orn salt solid 100g is added in 500g acetic acid aqueous solution (50% concentration), is stirred Dissolution completely, is added salicylide 10g, is heated to 70 DEG C of stirring 3.5h in Xiang Shangshu solution;
2) step 1) acquired solution is kept the temperature 50~60 DEG C, methanol 500g, time for adding 2.5h, during dropwise addition is added dropwise It gradually precipitates crystal, insulated and stirred 4h growing the grain is added dropwise, is cooled to 30 DEG C, the solid was filtered, and 45 DEG C of drying 6h of vacuum must consolidate Body 86.7g.Yield 86.7%, purity 99.7%.
This product is taken, it is accurately weighed, the solution in every 1ml containing 80mg is made, the temperature of test liquid should be 20 DEG C ± 0.5 DEG C, It is 0 ° that detection, which calculates specific rotatory power,.
The preparation of embodiment 2:DL- L-aminobutanedioic acid DL- ornithine
1) L-ASPARTIC ACID L-Orn salt solid 100g is added in 600g acetic acid aqueous solution (40% concentration), is stirred Dissolution completely, is added salicylide 8g, is heated to 70 DEG C of stirring 4h in Xiang Shangshu solution;
2) step 1) acquired solution is kept the temperature into 50 DEG C of dropwise additions methanol 500g, time for adding 2h, is gradually analysed during being added dropwise Crystal out is added dropwise insulated and stirred 3h growing the grain, is cooled to 35 DEG C, and the solid was filtered, and 50 DEG C of drying 6h of vacuum obtain solid 82.4g.Yield 82.4%, purity 99.6%.
This product is taken, it is accurately weighed, the solution in every 1ml containing 80mg is made, the temperature of test liquid should be 20 DEG C ± 0.5 DEG C, It is 0 ° that detection, which calculates specific rotatory power,.
The preparation of embodiment 3:DL- L-aminobutanedioic acid DL- ornithine
1) L-ASPARTIC ACID L-Orn salt solid 100g is added in 500g acetic acid aqueous solution (50% concentration), is stirred Dissolution completely, is added salicylide 10g, is heated to 65 DEG C of stirring 3.5h in Xiang Shangshu solution;
2) step 1) acquired solution is kept the temperature into 50~60 DEG C of dropwise additions ethyl alcohol 400g, time for adding 2.5h, during dropwise addition It gradually precipitates crystal, insulated and stirred 4h growing the grain is added dropwise, is cooled to 30 DEG C, the solid was filtered, and 45 DEG C of drying 6h of vacuum must consolidate Body 84.7g.Yield 84.7%, purity 99.6%.
This product is taken, it is accurately weighed, the solution in every 1ml containing 80mg is made, the temperature of test liquid should be 20 DEG C ± 0.5 DEG C, It is 0 ° that detection, which calculates specific rotatory power,.
Although above the present invention is described in detail with a general description of the specific embodiments, On the basis of the present invention, it can be made some modifications or improvements, this will be apparent to those skilled in the art.Cause This, these modifications or improvements, fall within the scope of the claimed invention without departing from theon the basis of the spirit of the present invention.

Claims (12)

1. a kind of preparation method of DL- L-aminobutanedioic acid DL- ornithine, which comprises the following steps:
(1) using acetic acid aqueous solution as solvent, L-ASPARTIC ACID L-Orn salt disappears in 60~80 DEG C under the action of catalyst Rotation reaction, obtains racemization liquid;
The catalyst is selected from salicylide or benzaldehyde;
(2) anti-solvent is added into racemization liquid, the anti-solvent need to be added in racemization liquid in a manner of dropwise addition, and during dropwise addition Temperature control is at 45~65 DEG C, crystallization, filtering, drying to get;
The anti-solvent is selected from one of methanol, ethyl alcohol, isopropanol or a variety of.
2. the preparation method of DL- L-aminobutanedioic acid DL- ornithine according to claim 1, which is characterized in that in step (1), The mass concentration of the acetic acid aqueous solution is 40~60%;The additional amount of the acetic acid aqueous solution is L-ASPARTIC ACID L-Orn 4~7 times of salt quality.
3. the preparation method of DL- L-aminobutanedioic acid DL- ornithine according to claim 2, which is characterized in that the acetic acid water The additional amount of solution is 5~6 times of L-ASPARTIC ACID L-Orn salt quality.
4. the preparation method of DL- L-aminobutanedioic acid DL- ornithine according to claim 1, which is characterized in that in step (1), The dosage of the catalyst is the 5~10% of L-ASPARTIC ACID L-Orn salt quality.
5. the preparation method of DL- L-aminobutanedioic acid DL- ornithine according to claim 4, which is characterized in that in step (1), The dosage of the catalyst is the 8~10% of L-ASPARTIC ACID L-Orn salt quality.
6. the preparation method of DL- L-aminobutanedioic acid DL- ornithine according to claim 1, which is characterized in that in step (1), The temperature of the racemization controls between 70~80 DEG C.
7. the preparation method of -6 any DL- L-aminobutanedioic acid DL- ornithines according to claim 1, which is characterized in that step (2) in, temperature control is at 50~60 DEG C during the dropwise addition.
8. the preparation method of DL- L-aminobutanedioic acid DL- ornithine according to claim 7, which is characterized in that in step (2), After the crystallization, system is cooled to 20~40 DEG C of crystallizations.
9. the preparation method of DL- L-aminobutanedioic acid DL- ornithine according to claim 8, which is characterized in that in step (2), After the crystallization, system is cooled to 30~35 DEG C.
10. the preparation method of DL- L-aminobutanedioic acid DL- ornithine according to claim 9, which is characterized in that step (2) In, the drying uses vacuum drying mode, and temperature controls between 40~60 DEG C, and vacuum degree is -0.08~-0.1MPa.
11. the preparation method of DL- L-aminobutanedioic acid DL- ornithine according to claim 10, which is characterized in that step (2) In, the drying uses vacuum drying mode, and temperature controls between 45~50 DEG C.
12. the preparation method of DL- L-aminobutanedioic acid DL- ornithine according to claim 1, which is characterized in that including as follows Step:
(1) L-ASPARTIC ACID L-Orn salt is added in acetic acid aqueous solution and is dissolved completely, be added catalyst, heating 60~ Racemization is carried out between 80 DEG C, obtains racemization liquid;
(2) under heat-retaining condition, anti-solvent is added dropwise into racemization liquid, temperature control is precipitated simultaneously at 45~65 DEG C during dropwise addition Rear 2~4h of insulated and stirred is added dropwise in a large amount of crystal, is cooled to 20~40 DEG C of crystallizations, and the solid was filtered, carries out in 40~60 DEG C Vacuum drying to get.
CN201710239961.1A 2017-04-13 2017-04-13 A kind of preparation method of DL- L-aminobutanedioic acid DL- ornithine Active CN106977413B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201710239961.1A CN106977413B (en) 2017-04-13 2017-04-13 A kind of preparation method of DL- L-aminobutanedioic acid DL- ornithine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201710239961.1A CN106977413B (en) 2017-04-13 2017-04-13 A kind of preparation method of DL- L-aminobutanedioic acid DL- ornithine

Publications (2)

Publication Number Publication Date
CN106977413A CN106977413A (en) 2017-07-25
CN106977413B true CN106977413B (en) 2019-03-05

Family

ID=59345718

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201710239961.1A Active CN106977413B (en) 2017-04-13 2017-04-13 A kind of preparation method of DL- L-aminobutanedioic acid DL- ornithine

Country Status (1)

Country Link
CN (1) CN106977413B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110317144A (en) * 2018-03-28 2019-10-11 上海贵之言医药科技有限公司 A kind of aspartic acid ornithine Crystal form of double salt compound and preparation method thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2851482A (en) * 1957-05-20 1958-09-09 Gen Mills Inc L-arginine-l-glutamate
CN101284796A (en) * 2008-05-30 2008-10-15 何关昌 Process for preparing DL-phenylalanine and DL-asparaginic acid by mother liquor reclamation

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2851482A (en) * 1957-05-20 1958-09-09 Gen Mills Inc L-arginine-l-glutamate
CN101284796A (en) * 2008-05-30 2008-10-15 何关昌 Process for preparing DL-phenylalanine and DL-asparaginic acid by mother liquor reclamation

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
"化学酶法制备D-鸟氨酸盐酸盐";刘莉等;《安徽农业科学》;20091231;第37卷(第20期);9317-9319
"药用氨基酸复合盐的合成研究";郑岚等;《化学试剂》;20090930;第31卷(第9期);740-742

Also Published As

Publication number Publication date
CN106977413A (en) 2017-07-25

Similar Documents

Publication Publication Date Title
CN105384735A (en) Preparation method for bulk crystal product of thiamine nitrate
CN103167872B (en) For the production of the method for VBT tartrate
CN102557918B (en) Ibuprofen sodium compound and new preparation method thereof
CN104829478A (en) Preparation process of D-phenylglycine methyl ester hydrochloride crystals
CN106977413A (en) A kind of preparation method of DL L-aminobutanedioic acids DL ornithines
JP4453070B2 (en) Process for producing 5'-disodium guanylate / disodium 5'-inosinate mixed crystal
CN109134430A (en) A kind of method that HPLC method prepares Rabeprazole impurity
CN107400114A (en) Dilution crystallization purifies Rynaxypyr
CN106748840A (en) A kind of method for preparing 5 amino isophthalic acids
CN109134331A (en) The synthetic method of azithromycin genotoxicity impurity
CN103524490B (en) A kind of method for preparing amorphous esomeprazole magnesium salt
JP5743474B2 (en) Process for producing 4-amino-5-chloro-2-ethoxy-N-[[4- (4-fluorobenzyl) -2-morpholinyl] methyl] benzamide citrate dihydrate
CN106748835A (en) A kind of preparation method of stryphnonasal
CN107245027A (en) A kind of preparation method of D mannitol alpha crystal formations
CN113880708B (en) A kind of preparation method of 4-cyclohexyl benzoic acid
CN108558676B (en) Preparation method of N, N-dibenzylethylenediamine diacetate
CN108752216B (en) Green preparation method of high-purity N, N' -dibenzyl ethylenediamine diacetic acid
US10654793B2 (en) Production method for 1-amino cyclopropane carboxylic acid nonhydrate
CN114163438A (en) Preparation method of 2-methyl-3-carbonyl pyrazolo [4,3-c ] pyridine-7-carboxylic acid hydrochloride
CN119462445A (en) A preparation method of S-carboxymethyl-L-cysteine sulfone
CN112390779B (en) Preparation method of dextro lipoic acid
CN113135897B (en) Rupatadine fumarate B crystal form and preparation method thereof
CN109438278A (en) A kind of occrycetin preparation method
CN107337708A (en) Pidotimod novel crystal forms and preparation method thereof
JP6147546B2 (en) Method for producing telmisartan A-type crystals with reduced acetic acid

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant